Lisa Berquist

A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity

Jianying Dong, Arlene Sereno, Dikran Aivazian et al. · mAbs · 2011 · 79 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site

Soulaïma Chamat, P L Nara, Lisa Berquist et al. · The Journal of Immunology · 1992 · 50 citations

Life Sciences, Immunology, Infectious Diseases +17

Development of an Fn14 agonistic antibody as an anti-tumor agent

Jennifer S. Michaelson, Aldo Amatucci, Rebecca K. Kelly et al. · mAbs · 2011 · 49 citations · Full text

Medicine, Oncology, Pharmacology +12

Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity

Jianying Dong, Arlene Sereno, William B. Snyder et al. · Journal of Biological Chemistry · 2010 · 38 citations · Full text

Medicine, Cancer Biology, Oncology +14

Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in PROVAX.

Kandasamy Hariharan, Gary R. Braslawsky, Richard S. Barnett et al. · International Journal of Oncology · 1998 · 31 citations

Medicine, Immunology, Oncology +17